Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06985524

To Observe the Clinical Efficacy of Traditional Chinese Medicine Compound(Weipi Formula ) in the Treatment of Epigastric Stuffiness Syndrome

Clinical and Preparation Studies of Traditional Chinese Medicine Compound(Weipi Formula) in the Treatment of Epigastric Stuffiness Syndrome

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
256 (estimated)
Sponsor
Second Affiliated Hospital of Nanchang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical trial is to evaluate the efficacy of the herbal drug Weipi formula in treating functional dyspepsia (FD) in adults. It will also assess the safety of Weipi formula. The main questions the study aims to answer are: Does Weipi formula reduce participants' TCM syndrome scores? What medical issues might participants experience while taking Weipi formula? Researchers will compare Weipi formula with a placebo (an identical-looking substance without active drugs) to determine whether Weipi formula is effective in treating functional dyspepsia. Participant Procedures Participants will: Take Weipi formula or the placebo daily for 2 weeks. Visit the clinic once every week for examinations and tests. Record their symptoms and undergo measurements (e.g., pepsin levels).

Conditions

Interventions

TypeNameDescription
DRUGWeipi Formula(Wu SiSi Formula)take Weipi Formula(Wu SiSi Formula) or the placebo daily for 2 weeks.
OTHERPlaceboTake Weipi Formula(Wu SiSi Formula) or the placebo daily for 2 weeks.

Timeline

Start date
2024-01-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-05-22
Last updated
2025-05-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06985524. Inclusion in this directory is not an endorsement.